Drug Markets/Bleomycin

Bleomycin

4 NDCs across 3 manufacturers|4 Generic,0 Brand

Bleomycin is used to treat squamous cell carcinoma, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, melanoma and sarcoma, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Bleomycin is available as 4 NDCs from 3 manufacturers (4 generic, 0 brand), with NADAC prices from $26.45 to $26.45 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

3

competing in market

Price Spread

$26.45 – $26.45

per EA

7d Activity

4 flat

avg +0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Bleomycin used to treat?

Bleomycin is used to treat squamous cell carcinoma, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, melanoma and sarcoma, per the National Library of Medicine's MED-RT classification.

How many Bleomycin products are on the market?

The Bleomycin drug market contains 4 NDCs from 3 manufacturers — 4 generic and 0 brand products.

What is the price range for Bleomycin?

NADAC reference prices for Bleomycin range from $26.4480 to $26.4480 per EA.

Which manufacturers make Bleomycin?

3 manufacturers list Bleomycin in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (2), NorthStar Rx LLC (1), Hikma Pharmaceuticals USA Inc. (1).